Ovarian Cancer Clinical Trial

Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer

Summary

The purpose of this study is to learn more about the factors that influence decision-making before surgery (distress about cancer and/or reproductive concerns) and the possibility of regret after surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women aged ≥ 18 and ≤ 50 years
Premenopausal
Endometrioid histological diagnosis
Scheduled for surgical intervention at MSKCC
FIGO grade 1-2, clinical stage I
Disease confined to uterus, no clear evidence of deep (≥50%) myoinvasion on imaging (MRI preferred, ultrasound optional)
Normal ovaries on preoperative imaging
Able to provide informed consent
English-speaking

Exclusion Criteria:

Known Lynch syndrome
Prior bilateral oophorectomy
Personal history of hormone receptor-positive breast carcinoma
Increased risk of ovarian cancer identified on the basis of family or personal history
Women currently on hormonal contraception, letrozole, or tamoxifen may not opt-in to AMH
Women who recently underwent ovarian stimulation within the past 3 months may not opt-in to AMH
Women who have pituitary dysfunction (or any pituitary disorders) may not opt-in to AMH
Women who completed chemotherapy within <12 months may not opt-in to AMH

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

100

Study ID:

NCT04569773

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown New Jersey, 07748, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Bergen (All protocol activities)
Montvale New Jersey, 07645, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Cancer Center @ Suffolk (All protocol activities)
Commack New York, 11725, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Westchester (All protocol activities)
Harrison New York, 10604, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Cancer Center (All Study Activities)
New York New York, 10065, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229
Memorial Sloan Kettering Nassau (All protocol activities)
Rockville Centre New York, 11553, United States More Info
Jennifer Mueller, MD
Contact
212-639-8229

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

100

Study ID:

NCT04569773

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.